Gloved hands pipetting liquid into a vial
Our Work

Latham Advises on Financing for Audax Private Equity’s Acquisition of Avantor’s Clinical Services Business

August 19, 2024
Firm represents the private credit funds supporting the private equity firm’s acquisition of the life sciences tools company.

Audax Private Equity has announced it has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. (NYSE: AVTR), a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The deal is expected to close in the fourth quarter and is subject to regulatory approvals.

Latham & Watkins LLP represented the private credit funds in a financing to support the acquisition with a team led by partners Stelios Saffos, Conray Tseng, and Peter Sluka, with associate Ana Nunez Cardenas. Advice was also provided on data privacy matters by associate Kathryn Parsons-Reponte; on intellectual property matters by partner Jeffrey Tochner, with associate Sebastian Moss; on tax matters by partner Bora Bozkurt, with associate Kathryn Harrington; and on uniform commercial code matters by partner Larry Safran.

Endnotes